Improved outcomes and staging in non-small-cell lung cancer guided by a molecular assay

There remains a critical need for improved staging of non-small-cell lung cancer, as recurrence and mortality due to undetectable metastases at the time of surgery remain high even after complete resection of tumors currently categorized as ‘early stage.’ A 14-gene quantitative PCR-based expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Alexander R, Woodard, Gavitt A, Jablons, David M, Mann, Michael J, Kratz, Johannes R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039775/
https://www.ncbi.nlm.nih.gov/pubmed/34435876
http://dx.doi.org/10.2217/fon-2021-0517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039775/
https://www.ncbi.nlm.nih.gov/pubmed/34435876
http://dx.doi.org/10.2217/fon-2021-0517

Ejemplares similares